Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
20.33x2.41x-4.28x4.71x13.35x14.46x0.49% 8.24TCr
44.79x4.94x3.98x7.03x22.23x30.43x0.51% 6.3TCr
51.52x6.93x1.23x13.6x29.17x36.53x-.--% 5.49TCr
37x2.63x-0.69x3.8x10.99x12.48x2.76% 5.11TCr
16.55x1.42x0.47x3.06x8.89x9.84x-.--% 2.88TCr
15.89x2.74x-21.32x2.61x8.26x7.76x-.--% 2.01TCr
76.53x7.83x-0.04x9.44x89.22x88.13x-.--% 1.97TCr
685.93x3.54x-7.24x5.33x13.63x43x-.--% 1.58TCr
-5.35x1.92x0.36x6.21x-3.73x-3.53x-.--% 1.65TCr
-21.82x-7.14x-1.1x31.67x-32.16x-31.28x-.--% 1.45TCr
291.45x57.47x22.95x97.86x178.17x184.28x - 1.42TCr
24.11x - 1.95x3.22x16.55x16.27x-.--% 1.15TCr
-16.27x - -0.3x585.65x-15.96x-16.18x-.--% 1.1TCr
-47.89x198.62x1.3x14.16x-56.91x-52.73x-.--% 913.53Cr
40.53x - 0.32x19.37x45.57x46.62x-.--% 801.64Cr
17.59x1.17x0.1x2.06x8.55x11.37x1.47% 790.73Cr
5.28x2.05x0.01x2.27x3.38x3.43x3.83% 747.62Cr
-222.12x - 0.68x - - - -.--% 735.01Cr
20.8x1.23x-2.29x - - - 1.28% 596.55Cr
-12.66x1.4x0.05x3.86x-25.79x-26.28x-.--% 585.58Cr
Average 51.11x 18.07x -0.19x 45.33x 17.41x 20.81x 0.54% 2.28TCr
Weighted average by Cap. 54.12x 9.41x -0.57x 24.75x 20.04x 23.91x 0.59%
Biopharmaceuticals